{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:13Z","timestamp":1792723093288,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG028716"],"award-info":[{"award-number":["P30-AG028716"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.joca.2026.10.002","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:21:33Z","timestamp":1791645693000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fundamentals of osteoarthritis: Biomarkers"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8173-8258","authenticated-orcid":false,"given":"Virginia Byers","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-8740","authenticated-orcid":false,"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2026.10.002_bib1","series-title":"Biochemical Markers","author":"Rousseau","year":"2012"},{"key":"10.1016\/j.joca.2026.10.002_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.joca.2021.04.019","article-title":"Clinical monitoring in osteoarthritis: biomarkers","volume":"30","author":"Kraus","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"NIH","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.joca.2026.10.002_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2006.04.001","article-title":"Classification of osteoarthritis biomarkers: a proposed approach","volume":"14","author":"Bauer","year":"2006","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.joca.2010.08.019","article-title":"Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis","volume":"19","author":"Kraus","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib6","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2016"},{"key":"10.1016\/j.joca.2026.10.002_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.joca.2018.11.002","article-title":"Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs","volume":"27","author":"Kraus","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.07.016","article-title":"A framework and shared vocabulary to identify actionable protein biomarkers and enable optimal precision medicine: myth-busting with unicorn biomarkers","author":"Karsdal","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.joca.2026.10.002_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s41927-025-00557-0","article-title":"Towards stratification in osteoarthritis: a review of the scientific terminology used in published basic research","volume":"9","author":"Pattappa","year":"2025","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s00264-026-06845-9","article-title":"Osteoarthritis phenotypes: advancing precision medicine through clinical, structural, and molecular stratification","author":"Vaishya","year":"2026","journal-title":"Int. Orthop."},{"key":"10.1016\/j.joca.2026.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12998","article-title":"Growth differentiation factor 5 in cartilage and osteoarthritis: a possible therapeutic candidate","volume":"54","author":"Sun","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.joca.2026.10.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100572","article-title":"The inflammatory endotype in osteoarthritis: reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development","volume":"7","author":"Karsdal","year":"2025","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.joca.2026.10.002_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.joca.2021.10.008","article-title":"Low levels of type II collagen formation (PRO-C2) are associated with response to sprifermin: a pre-defined, exploratory biomarker analysis from the FORWARD study","volume":"30","author":"Bay-Jensen","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67730-y","article-title":"Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis","volume":"10","author":"Chou","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.joca.2026.10.002_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.joca.2010.01.012","article-title":"Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria","volume":"18","author":"van Spil","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib16","series-title":"Biochemistry of Collagens, Laminins and Elastin: Structure, Function and Biomarkers","author":"Karsdal","year":"2024"},{"key":"10.1016\/j.joca.2026.10.002_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41584-024-01102-y","article-title":"Molecular biomarker approaches to prevention of post-traumatic osteoarthritis","volume":"20","author":"Kraus","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq5095","article-title":"A \u2018best-in-class\u2019 systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression","volume":"9","author":"Zhou","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.joca.2026.10.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109812","article-title":"Comprehensive characterization of pathogenic synovial fluid extracellular vesicles from knee osteoarthritis","volume":"257","author":"Zhang","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.joca.2026.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2023.100425","article-title":"Serum proteomic panel validated for prediction of knee osteoarthritis progression","volume":"6","author":"Kraus","year":"2024","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.joca.2026.10.002_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13018-025-06604-3","article-title":"Integrative multi-omics analysis reveals gut microbiota-derived metabolites and immune regulatory pathways in osteoarthritis pathogenesis","volume":"21","author":"Wang","year":"2026","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.joca.2026.10.002_bib22","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.41793","article-title":"The CRTAC1 protein in plasma is associated with osteoarthritis and predicts progression to joint replacement: a large-scale proteomics scan in Iceland","volume":"73","author":"Styrkarsdottir","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/rheumatology\/keac415","article-title":"Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression","volume":"62","author":"Szilagyi","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2026.10.002_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/art.42376","article-title":"Cartilage acidic protein 1 in plasma associates with prevalent osteoarthritis and predicts future risk as well as progression to joint replacements: results from the UK biobank resource","volume":"75","author":"Styrkarsdottir","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3899\/jrheum.2023-0684","article-title":"Plasma cartilage acidic protein 1 measured by ELISA is associated with the progression to total joint replacement in postmenopausal women","volume":"51","author":"Garnero","year":"2024","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj6814","article-title":"An osteoarthritis pathophysiological continuum revealed by molecular biomarkers","volume":"10","author":"Kraus","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.joca.2026.10.002_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/art.43143","article-title":"Plasma proteomic profiles predict individual future osteoarthritis risk","volume":"77","author":"Kang","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2026.100769","article-title":"CSPG4(+) extracellular vesicles carry fibronectin and interleukin-11 and reflect radiographic severity in knee osteoarthritis","volume":"8","author":"Zhang","year":"2026","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.joca.2026.10.002_bib29","article-title":"TNF-\u03b1 carried by plasma extracellular vesicles predicts knee osteoarthritis progression","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.joca.2026.10.002_bib30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/art.42455","article-title":"Association of dipeptidylpeptidase 4 (CD26) with chondrocyte senescence and radiographic progression in knee osteoarthritis","volume":"75","author":"Chen","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X261434279","article-title":"Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes","volume":"18","author":"Chen","year":"2026","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","article-title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1\u03b1 and anti-interleukin-1\u03b2 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/14737159.2025.2550639","article-title":"Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials","volume":"25","author":"Thudium","year":"2025","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.joca.2026.10.002_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3899\/jrheum.200054","article-title":"Phenylalanine is a novel marker for radiographic knee osteoarthritis progression: the MOST study","volume":"48","author":"Zhai","year":"2021","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12967-025-06310-y","article-title":"Multi-omics analysis of synovial tissue and fluid reveals differentially expressed proteins and metabolites in osteoarthritis","volume":"23","author":"Ge","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.joca.2026.10.002_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231177116","article-title":"Emerging molecular biomarkers in osteoarthritis pathology","volume":"15","author":"Sandhu","year":"2023","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib37","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1074\/jbc.M111.249649","article-title":"Protein modification by deamidation indicates variations in joint extracellular matrix turnover","volume":"287","author":"Catterall","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.joca.2026.10.002_bib38","doi-asserted-by":"crossref","first-page":"1637s","DOI":"10.1177\/19476035211021892","article-title":"Cartilage biomarkers Coll2-1 and Coll2-1NO2 are associated with knee OA MRI features and are helpful in identifying patients at risk of disease worsening","volume":"13","author":"Hick","year":"2021","journal-title":"Cartilage"},{"key":"10.1016\/j.joca.2026.10.002_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126352","article-title":"The role of microRNAs in the pathophysiology of osteoarthritis","volume":"25","author":"Szala","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9936295","article-title":"Plasma microRNA-320c as a potential biomarker for the severity of knee osteoarthritis and regulates cAMP responsive element binding protein 5 (CREB5) in chondrocytes","volume":"2024","author":"Zhou","year":"2024","journal-title":"Dis. Markers"},{"key":"10.1016\/j.joca.2026.10.002_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001380","article-title":"Prognosis research strategy (PROGRESS) 2: prognostic factor research","volume":"10","author":"Riley","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.joca.2026.10.002_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14737159.2025.2550639","article-title":"Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials","volume":"25","author":"Thudium","year":"2025","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.joca.2026.10.002_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/rth2.12355","article-title":"Plasminogen activation in the musculoskeletal acute phase response: injury, repair, and disease","volume":"4","author":"Gibson","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.joca.2026.10.002_bib44","doi-asserted-by":"crossref","first-page":"32301","DOI":"10.1074\/jbc.M504828200","article-title":"The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q","volume":"280","author":"Sj\u00f6berg","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.joca.2026.10.002_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-016-1123-x","article-title":"The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis","volume":"18","author":"Struglics","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.joca.2026.10.002_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity - a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.joca.2026.10.002_bib47","article-title":"Immune system-related plasma pathogenic extracellular vesicle subpopulations predict osteoarthritis progression","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib48","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s11357-024-01454-z","article-title":"Plasma extracellular vesicles carry immune system-related peptides that predict human longevity","volume":"47","author":"Zhang","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.joca.2026.10.002_bib49","first-page":"17","article-title":"Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum","author":"Perry","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.joca.2026.10.002_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/M20-0527","article-title":"Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial","volume":"173","author":"Schieker","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.joca.2026.10.002_bib51","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/DMSO.S520465","article-title":"Is it time to revisit the role of interleukin-1 inhibitors in osteoarthritis?","volume":"18","author":"Brom","year":"2025","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.joca.2026.10.002_bib52","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1186\/s12967-025-07379-1","article-title":"Exosomes in aging and age-related disorders: mechanisms, therapeutic potentials, and challenges","volume":"23","author":"Safaei","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.joca.2026.10.002_bib53","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/03008207.2025.2524064","article-title":"Extracellular vesicles in cartilage homeostasis, osteoarthritis, and biomarker discovery","volume":"66","author":"Clarke","year":"2025","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.joca.2026.10.002_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123365","article-title":"Current status, opportunities, and challenges of exosomes in diagnosis and treatment of osteoarthritis","volume":"362","author":"Okuyan","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib55","article-title":"Extracellular vesicles as biological indicators and potential sources of autologous therapeutics in osteoarthritis","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41584-023-01010-7","article-title":"Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells","volume":"19","author":"Bertolino","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib57","article-title":"Extracellular vesicles in osteoarthritis: mechanisms, therapeutic potential, and diagnostic applications","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.joca.2026.10.002_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1570526","article-title":"Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives","volume":"13","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.joca.2026.10.002_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119064","article-title":"The dual role of extracellular vesicles in OA: pathological mediators, diagnostic biomarkers, and therapeutic targets","volume":"196","author":"Leng","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.joca.2026.10.002_bib60","article-title":"Exosomes in osteoarthritis: emerging roles in pathogenesis, diagnosis, and therapeutic potential","volume":"12","author":"Bagherifard","year":"2026","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.joca.2026.10.002_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.joca.2026.10.002_bib62","first-page":"1","article-title":"Clinical development success rates 2006\u20132015. Biotechnology Innovation Organization (BIO)","author":"Thomas","year":"2016","journal-title":"Biomedtrack. Amplion"},{"key":"10.1016\/j.joca.2026.10.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100677","article-title":"Biochemical biomarkers of knee osteoarthritis progression: Results from the FNIH biomarkers consortium progress OA study","volume":"7","author":"Collins","year":"2025","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.joca.2026.10.002_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/art.40348","article-title":"Predictive validity of radiographic trabecular bone texture in knee osteoarthritis: the osteoarthritis research society international\/foundation for the National Institutes of Health osteoarthritis biomarkers consortium","volume":"70","author":"Kraus","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib65","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib66","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.61.6.530","article-title":"Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products","volume":"61","author":"Lehmann","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib67","unstructured":"Food and Drug Administration, Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment Guidance for Industry, 2018."},{"key":"10.1016\/j.joca.2026.10.002_bib68","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.joca.2018.12.001","article-title":"Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients","volume":"27","author":"Karsdal","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib69","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1078-0432.CCR-24-2729","article-title":"Challenges to innovation arising from current companion diagnostic regulations and suggestions for improvements","volume":"31","author":"Oliner","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.joca.2026.10.002_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101063","article-title":"The current landscape of the FDA approved companion diagnostics","volume":"14","author":"J\u00f8rgensen","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.joca.2026.10.002_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/nyas.12754","article-title":"Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics","volume":"1346","author":"Batrla","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib72","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.joca.2026.10.002_bib73","article-title":"Magnetic resonance imaging biomarkers of knee osteoarthritis progression","volume":"7","author":"Collins","year":"2025","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib74","doi-asserted-by":"crossref","DOI":"10.1177\/19476035251395177","article-title":"Combining machine-learning assessment of multiple MRI pathologies and clinical phenotypes for predicting joint replacement in knee osteoarthritis: data from the osteoarthritis initiative","author":"D'Assignies","year":"2025","journal-title":"Cartilage"},{"key":"10.1016\/j.joca.2026.10.002_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2026.02.001","article-title":"Feasibility and predictive value of proposed early endpoints for randomized controlled trials in knee osteoarthritis","author":"Collins","year":"2026","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib76","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/annrheumdis-2013-203631","article-title":"What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?","volume":"72","author":"Pelletier","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib77","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.joca.2020.03.012","article-title":"Predicting knee replacement in participants eligible for disease-modifying osteoarthritis drug treatment with structural endpoints","volume":"28","author":"Kwoh","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib78","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12891-016-1310-6","article-title":"Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort \u2013 methodologic aspects and definition of change","volume":"17","author":"Roemer","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.joca.2026.10.002_bib79","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.39731","article-title":"Semiquantitative imaging biomarkers of knee osteoarthritis progression: data from the foundation for the National Institutes of Health osteoarthritis biomarkers consortium","volume":"68","author":"Collins","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.10.002_bib80","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/acr.24557","article-title":"Multivariable modeling of biomarker data from the phase I foundation for the National Institutes of Health osteoarthritis biomarkers consortium","volume":"74","author":"Hunter","year":"2022","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.joca.2026.10.002_bib81","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","article-title":"Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium","volume":"76","author":"Kraus","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib82","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00256-023-04284-w","article-title":"Biomarkers in osteoarthritis: current status and outlook \u2013 the FNIH biomarkers consortium PROGRESS OA study","volume":"52","author":"Hunter","year":"2023","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.joca.2026.10.002_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.4433","article-title":"Validation of the surrogate threshold effect for change in bone mineral density as a surrogate endpoint for fracture outcomes: the FNIH-ASBMR SABRE project","volume":"37","author":"Eastell","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.joca.2026.10.002_bib84","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/jbmr\/zjae126","article-title":"The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project","volume":"39","author":"Vilaca","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.joca.2026.10.002_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2022.100262","article-title":"Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development \u2013 should future studies focus on disease activity, rather than status?","volume":"4","author":"Karsdal","year":"2022","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.joca.2026.10.002_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2023.06.006","article-title":"Reflections from the OARSI 2022 clinical trials symposium: the pain of OA-Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design","author":"Karsdal","year":"2023","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib87","unstructured":"Anonymous, ARPA-H's First Program NITRO Selects Teams to Lead Breakthroughs in Reversing Osteoarthritis, vol. 2026, ARPA H, 2024."},{"key":"10.1016\/j.joca.2026.10.002_bib88","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.joca.2024.02.711","article-title":"Changes in the synovial fluid proteome align with the transition of cartilage degeneration after ACL injury","volume":"32","author":"Hsueh","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib89","article-title":"The PIKASO trial (preventing injured knees from osteoarthritis: severity outcomes): rationale and design features for a randomized controlled trial","volume":"7","author":"Jacobs","year":"2025","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.joca.2026.10.002_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202300210","article-title":"Dried blood spot analysis with liquid chromatography and mass spectrometry: trends in clinical chemistry","volume":"46","author":"Skogvold","year":"2023","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib91","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s13361-013-0678-x","article-title":"Comparison of proteins in whole blood and dried blood spot samples by LC\/MS\/MS","volume":"24","author":"Chambers","year":"2013","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.joca.2026.10.002_bib92","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clinms.2019.03.002","article-title":"Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry","volume":"12","author":"Samenuk","year":"2019","journal-title":"Clin. Mass Spectrom."},{"key":"10.1016\/j.joca.2026.10.002_bib93","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/acs.jproteome.0c00271","article-title":"Simple and sensitive analysis for dried blood spot proteins by sodium carbonate precipitation for clinical proteomics","volume":"19","author":"Nakajima","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.joca.2026.10.002_bib94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ddtec.2021.06.006","article-title":"Data-independent acquisition (DIA): an emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters","volume":"39","author":"Li","year":"2021","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.joca.2026.10.002_bib95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.joca.2026.10.002_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu8440","article-title":"Anabolic indices of matrix proteins identify regenerative small RNA intrinsic to human cartilage","volume":"11","author":"Hsueh","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.joca.2026.10.002_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax3203","article-title":"Analysis of \"old\" proteins unmasks dynamic gradient of cartilage turnover in human limbs","volume":"5","author":"Hsueh","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.joca.2026.10.002_bib98","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.1038\/srep09259","article-title":"Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health","volume":"5","author":"Ahmed","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.joca.2026.10.002_bib99","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41591-024-03142-z","article-title":"Proteomic signatures improve risk prediction for common and rare diseases","volume":"30","author":"Carrasco-Zanini","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.joca.2026.10.002_bib100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.joca.2023.11.019","article-title":"Three decades of advancements in osteoarthritis research: insights from transcriptomic, proteomic, and metabolomic studies","volume":"32","author":"Rai","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib101","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ard.2025.01.012","article-title":"Deep learning-based clustering for endotyping and post-arthroplasty response classification using knee osteoarthritis multiomic data","volume":"84","author":"Rockel","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib102","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13075-025-03563-2","article-title":"Recent advances in omics and the integration of multi-omics in osteoarthritis research","volume":"27","author":"Liu","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.joca.2026.10.002_bib103","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231169839","article-title":"Latest insights in disease-modifying osteoarthritis drugs development","volume":"15","author":"Li","year":"2023","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.joca.2024.11.002","article-title":"Longitudinal stability of molecular endotypes of knee osteoarthritis patients","volume":"33","author":"Hannani","year":"2025","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.10.002_bib105","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20575.1","article-title":"Recent advances in understanding the phenotypes of osteoarthritis","volume":"8","author":"Mobasheri","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.joca.2026.10.002_bib106","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2012-201575","article-title":"Progression of osteoarthritis as a state of inertia","volume":"72","author":"Felson","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7165406","article-title":"Synovial fluid microRNA-210 as a potential biomarker for early prediction of osteoarthritis","volume":"2019","author":"Xie","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.joca.2026.10.002_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.522","article-title":"MicroRNA-145 attenuates TNF-\u03b1-driven cartilage matrix degradation in osteoarthritis via direct suppression of MKK4","volume":"8","author":"Hu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.joca.2026.10.002_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12752","article-title":"Evidence that miR-146a attenuates aging- and trauma-induced osteoarthritis by inhibiting Notch1, IL-6, and IL-1 mediated catabolism","volume":"17","author":"Guan","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.joca.2026.10.002_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010123","article-title":"Silencing miR-146a-5p protects against injury-induced osteoarthritis in mice","volume":"13","author":"Qin","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.joca.2026.10.002_bib111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/ijms26010283","article-title":"Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: causal Links, Biological Mechanisms, and Drug Interactions","volume":"26","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.joca.2026.10.002_bib112","article-title":"MicroRNA signature for early prediction of knee osteoarthritis structural progression using integrated machine and deep learning approaches","author":"Jamshidi","year":"2024","journal-title":"Osteoarthr. Cartil."}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458426010812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458426010812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:53:07Z","timestamp":1792720387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458426010812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":112,"alternative-id":["S1063458426010812"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2026.10.002","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fundamentals of osteoarthritis: Biomarkers","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2026.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}